Franck Amblard,Steven J. Coats,Raymond F. Schinazi
申请号:
US14066461
公开号:
US09809616B2
申请日:
2013.10.29
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The compounds are of the class of N4-hydroxycytidine nucleosides, modified monophosphate and phosphonates prodrugs analogs, and pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof, useful in treating HCV or Norovirus infections.